1. Home
  2. INVE vs CNTB Comparison

INVE vs CNTB Comparison

Compare INVE & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$4.01

Market Cap

115.7M

Sector

Technology

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.17

Market Cap

135.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVE
CNTB
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.7M
135.7M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
INVE
CNTB
Price
$4.01
$2.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.50
$8.67
AVG Volume (30 Days)
127.7K
173.1K
Earning Date
05-13-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,219,000.00
$64,000.00
Revenue This Year
$22.10
N/A
Revenue Next Year
$20.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$3.08
$0.75
52 Week High
$5.30
$3.82

Technical Indicators

Market Signals
Indicator
INVE
CNTB
Relative Strength Index (RSI) 44.07 40.93
Support Level $3.17 $2.03
Resistance Level $4.07 $2.68
Average True Range (ATR) 0.19 0.19
MACD -0.01 -0.01
Stochastic Oscillator 42.97 8.48

Price Performance

Historical Comparison
INVE
CNTB

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: